Estimates Revisions Cartesian Therapeutics, Inc.
Stocks
RNAC
US8162123025
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 8.030 USD | +2.16% |
|
-1.95% | +11.37% |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- RNAC Stock
- Consensus Cartesian Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
